EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Newborn screening and biobanking for preventable genetic disorders in Mongolia: A developing country perspective

Khongorzul Batchuluun, Khishigjargal Batjargal, Altantuya Tsevgee, Altansuvd Enkhtur, Nurbyek Stipan, Elberelt Unurbat, Battogtokh Chimeddorj, Khurelbaatar Nyamdavaa, Damdindorj Boldbaatar, Erdenetuya Ganbaatar, Akihiro Umezawa

Regenerative Therapy · 2026-12 · 33 · 101163

DOI: 10.1016/j.reth.2026.101163 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Regenerative Therapy, 2026-12. Verfasst von Khongorzul Batchuluun und 10 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Sciences, Mongolian National University of Medical Sciences, Ulaanbaatar, 14210, Mongolia. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Newborn screening (NBS) is an important public health program, yet its implementation is highly uneven globally, with developing countries like Mongolia facing significant resource and infrastructure limitations that hinder early detection of preventable genetic disorders. Meanwhile, induced pluripotent stem cell (iPSC) technology, leveraged through biobanking, offers a powerful platform for disease modeling, drug discovery, and regenerative medicine, though its advanced applications are primarily concentrated in wealthier nations. We review the current status of NBS in Mongolia and argue for linking an expanded NBS program to an iPSC biobank. This link would improve diagnosis, create a foundation for Mongolian precision medicine, and strengthen local research capacity. We recognize the practical and ethical hurdles-funding, staffing, and data governance-and outline phased rollout, targeted training, and international partnerships as realistic next steps. Taken together, this approach could prevent avoidable disability in Mongolia while gradually building homegrown capability in genetic healthcare.

Autor:innen und Institutionen

  • Institute of Biomedical Sciences, Mongolian National University of Medical Sciences, Ulaanbaatar, 14210, Mongolia.
  • Department of Pediatrics, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, 14210, Mongolia.
  • Department of Physiology, School of Bio-Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, 14210, Mongolia.
  • National Center for Child Health and Development Research Institute, Tokyo, 157-8535, Japan.

Zitieren

APA

Batchuluun, K., Batjargal, K., Tsevgee, A., Enkhtur, A., Stipan, N., Unurbat, E., Chimeddorj, B., Nyamdavaa, K., Boldbaatar, D., Ganbaatar, E., & Umezawa, A. (2026). Newborn screening and biobanking for preventable genetic disorders in Mongolia: A developing country perspective. Regenerative Therapy, 33, 101163. https://doi.org/10.1016/j.reth.2026.101163

Vancouver

Batchuluun K, Batjargal K, Tsevgee A, Enkhtur A, Stipan N, Unurbat E, et al. Newborn screening and biobanking for preventable genetic disorders in Mongolia: A developing country perspective. Regenerative Therapy. 2026;33:101163. doi:10.1016/j.reth.2026.101163

BibTeX
@article{Batchuluun2026,
  author = {Batchuluun, Khongorzul and Batjargal, Khishigjargal and Tsevgee, Altantuya and Enkhtur, Altansuvd and Stipan, Nurbyek and Unurbat, Elberelt and Chimeddorj, Battogtokh and Nyamdavaa, Khurelbaatar and Boldbaatar, Damdindorj and Ganbaatar, Erdenetuya and Umezawa, Akihiro},
  title = {Newborn screening and biobanking for preventable genetic disorders in Mongolia: A developing country perspective},
  journal = {Regenerative Therapy},
  year = {2026},
  volume = {33},
  pages = {101163},
  doi = {10.1016/j.reth.2026.101163}
}
Kostenlos starten →